Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patriarca

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Annals of Hematology|March 31, 2018
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case reportAndrea Castelli, M L Mosca-Siez, P Riccomagno, et al.
The Journal of Infectious Diseases|February 1, 1997
The effect of diarrhea on oral poliovirus vaccine failure in BrazilD L Posey, R W Linkins, M J Oliveria, et al.
Minerva Ginecologica|December 1, 1987
[Female sterility of psychogenic origin]R Grio, A Cellura, F Zaccheo, et al.
The Journal of Infectious Diseases|February 1, 1997
Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study GroupJ F Modlin, N A Halsey, M L Thoms, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1982
Modification of the tubal peristaltic activity in vivo induced by a drug with anticholinergic activity in sterile womenS Rustichelli, M Mariatti, A Patriarca, et al.
The Journal of Pediatrics|April 1, 1986
Efficacy of acellular pertussis vaccineP A Patriarca, E W Brink, W A Orenstein, et al.
Minerva Ginecologica|April 1, 1986
[Venereal infections caused by Chlamydia trachomatis]R Grio, F Zaccheo, S Macchioni, et al.
Vaccine|July 12, 2002
Preparing for pandemic influenza: the need for enhanced surveillanceKathleen F Gensheimer, Keiji Fukuda, Lynette Brammer, et al.
Emerging Infectious Diseases|April 30, 1999
Preparing for pandemic influenza: the need for enhanced surveillanceK F Gensheimer, K Fukuda, L Brammer, et al.
Vaccine|February 1, 2011
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of ageR Baxter, P A Patriarca, K Ensor, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Annals of Hematology|March 31, 2018
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case reportAndrea Castelli, M L Mosca-Siez, P Riccomagno, et al.
The Journal of Infectious Diseases|February 1, 1997
The effect of diarrhea on oral poliovirus vaccine failure in BrazilD L Posey, R W Linkins, M J Oliveria, et al.
Minerva Ginecologica|December 1, 1987
[Female sterility of psychogenic origin]R Grio, A Cellura, F Zaccheo, et al.
The Journal of Infectious Diseases|February 1, 1997
Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study GroupJ F Modlin, N A Halsey, M L Thoms, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1982
Modification of the tubal peristaltic activity in vivo induced by a drug with anticholinergic activity in sterile womenS Rustichelli, M Mariatti, A Patriarca, et al.
The Journal of Pediatrics|April 1, 1986
Efficacy of acellular pertussis vaccineP A Patriarca, E W Brink, W A Orenstein, et al.
Minerva Ginecologica|April 1, 1986
[Venereal infections caused by Chlamydia trachomatis]R Grio, F Zaccheo, S Macchioni, et al.
Vaccine|July 12, 2002
Preparing for pandemic influenza: the need for enhanced surveillanceKathleen F Gensheimer, Keiji Fukuda, Lynette Brammer, et al.
Emerging Infectious Diseases|April 30, 1999
Preparing for pandemic influenza: the need for enhanced surveillanceK F Gensheimer, K Fukuda, L Brammer, et al.
Vaccine|February 1, 2011
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of ageR Baxter, P A Patriarca, K Ensor, et al.
Pageof 14